Related Experiment Video
Updated: Nov 30, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MicroRNAs in Podocyte Injury in Diabetic Nephropathy
Hiroki Ishii1, Shohei Kaneko1, Katsunori Yanai1
1Division of Nephrology, First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Abstract:
Diabetic nephropathy is one of the major complications of diabetes mellitus and is the leading cause of end-stage renal disease worldwide. Podocyte injury contributes to the development of diabetic nephropathy. However, the molecules that regulate podocyte injury in diabetic nephropathy have not been fully clarified. MicroRNAs (miRNAs) are small non-coding RNAs that can inhibit the translation of target messenger RNAs. Previous reports have described alteration of the expression levels of many miRNAs in cultured podocyte cells stimulated with a high glucose concentration and podocytes in rodent models of diabetic nephropathy. The associations between podocyte injury and miRNA expression levels in blood, urine, and kidney in patients with diabetic nephropathy have also been reported. Moreover, modulation of the expression of several miRNAs has been shown to have protective effects against podocyte injury in diabetic nephropathy in cultured podocyte cells in vitro and in rodent models of diabetic nephropathy in vivo. Therefore, this review focuses on miRNAs in podocyte injury in diabetic nephropathy, with regard to their potential as biomarkers and miRNA modulation as a therapeutic option.
Insights
MicroRNAs (miRNAs) are key regulators of podocyte injury in diabetic nephropathy. This review explores their potential as diagnostic biomarkers and therapeutic targets for this diabetes complication.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Diabetic nephropathy is a leading cause of end-stage renal disease, driven by podocyte injury.
- The molecular mechanisms regulating podocyte injury in diabetes remain incompletely understood.
- MicroRNAs (miRNAs) are implicated in cellular processes and disease development.
Purpose of the Study:
- To review the role of miRNAs in podocyte injury within diabetic nephropathy.
- To evaluate the potential of miRNAs as biomarkers for diabetic nephropathy.
- To discuss miRNA modulation as a therapeutic strategy for diabetic nephropathy.
Main Methods:
- Literature review of studies on miRNAs in diabetic nephropathy.
- Analysis of research on miRNA expression in diabetic podocytes (in vitro and in vivo).
- Examination of studies investigating miRNA biomarker potential and therapeutic modulation.
Main Results:
- Altered miRNA expression is observed in podocytes under high glucose conditions and in diabetic nephropathy models.
- miRNA expression levels correlate with podocyte injury in patients with diabetic nephropathy.
- Modulating specific miRNAs demonstrates protective effects against podocyte injury in experimental models.
Conclusions:
- miRNAs play a significant role in the pathogenesis of podocyte injury in diabetic nephropathy.
- miRNAs hold promise as non-invasive biomarkers for early detection and monitoring of diabetic nephropathy.
- Targeted miRNA-based therapies represent a potential future treatment strategy for diabetic nephropathy.
Related Concept Videos
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome I : Introduction
Nephrons

